4//SEC Filing
Heerma Peter 4
Accession 0001415889-25-002001
CIK 0001438533other
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 8:35 PM ET
Size
5.4 KB
Accession
0001415889-25-002001
Insider Transaction Report
Form 4
Heerma Peter
CHIEF COMMERCIAL OFFICER
Transactions
- Sale
Common Stock
2025-01-22$18.94/sh−1,584$30,002→ 106,374 total
Footnotes (1)
- [F1]Represents the number of shares required to be sold by the Reporting Person to cover the tax withholding obligation in connection with the settlement of vested restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the Reporting Person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the Reporting Person.
Documents
Issuer
Travere Therapeutics, Inc.
CIK 0001438533
Entity typeother
Related Parties
1- filerCIK 0001789617
Filing Metadata
- Form type
- 4
- Filed
- Jan 22, 7:00 PM ET
- Accepted
- Jan 23, 8:35 PM ET
- Size
- 5.4 KB